Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors
Clinical trial NCT03261011 · COMPLETED
Trial details
- NCT number
- NCT03261011
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2021-08-27
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.